Malignant melanoma is the fifth most common cancer in men and the sixth most common in women. Cutaneous malignant melanoma is the most common type of malignant melanoma. This activity reviews the AJCC staging and current guidelines from various professional societies for the evaluation of cutaneous malignant melanoma. It highlights the role of the interprofessional team in the comprehensive management of cutaneous malignant melanoma.

**Objectives:**
- Describe the epidemiology of cutaneous melanoma in the United States.
- Summarize the guidelines from the National Comprehensive Cancer Network (NCCN), Cancer Council Australia, American Association of Dermatology (AAD), and European Society of Medical Oncology (ESMO) for the diagnosis of cutaneous malignant melanoma
- Provide an overview of the recommendations for genetic counseling evaluation for patients with a personal or family history of cutaneous malignant melanoma
- Outline the recommendations for post-treatment surveillance by an interprofessional team of patients with cutaneous malignant melanoma.